Financial results 4Q & FY 2014. [7 tables in original article]
In: Chemical Business Newsbase, 2015-02-11
Zeitungsartikel
Zugriff:
On 11 Feb 2015, Royal DSM reported its unaudited results for 2014. DSM reported sales of EUR 9181 M, a 4% increase versus 2013. In line with market expectations, DSM reported EBITDA of EUR 1168 M compared to EUR 1261 M in 2013. The 4Q 2014 EBITDA was EUR 288 M compared to EUR 297 M in 4Q 2013. EBITDA of DSM's Nutrition segment for 4Q 2014 was EUR 200 M, down 4% compared to 4Q 2013. Actions to reduce inventories positively impacted cash flow but negatively impacted EBITDA. 2014 organic growth for the Nutrition cluster was 2% with 3% higher volumes driven by healthy growth in Animal Nutrition & Health (ANH), partly offset by weakness in Human Nutrition & Health (HNH). 2014 EBITDA of the cluster declined 7% in 2014, despite strong volume growth in ANH. The decline was due to the impact of negative currency effects, lower volumes in HNH and lower vitamin E prices. EBITDA in Performance Materials for the quarter was up 13% compared to 4Q 2013, largely driven by good volume growth, cost control and better efficiencies, resulting in improved margins. All three businesses contributed to this growth, with particular strong performance in DSM Dyneema. 2014 organic sales growth was 2%, with 4% higher volumes and 2% lower prices predominantly driven by lower raw materials costs. 2014 EBITDA was up 8% compared to 2013. All three business groups contributed to this growth, mainly due to higher volumes and continued cost control. EBITDA for the quarter declined compared to 4Q 2013 as higher sales were more than off-set by inventory adjustments and somewhat lower license income. 2014 organic sales growth was 9% compared to 2013 due to the increased caprolactam sales from the second line in China, partly offset by lower caprolactam prices. 2014 EBITDA decreased compared to 2013 given lower caprolactam margins and lower license income, despite higher volumes and lower costs. Three tables summarize the fey financial figures of DSM for 4Q 2013, 4Q 2014, 2013 and 2014. The other four tables focus on the key financial data of the company per business segment. Original Source: DSM, website: http://www.dsm.com/, Copyright Koninklijke DSM NV 2015.
Titel: |
Financial results 4Q & FY 2014. [7 tables in original article]
|
---|---|
Zeitschrift: | Chemical Business Newsbase, 2015-02-11 |
Veröffentlichung: | 2015 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|